Purlin Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -13.29%
- Profit Growth -60.45%
- Ebitda -53.84%
- Net Worth 163.85%
- Total Assets 32.62%
About Purlin Pharma
Purlin Pharma Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 May 2016 (Eight years and nine months 11 days old ). Its registered office is in Indore, Madhya Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurav Bagga and Falak Bagga serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999MP2016PTC040720
- Company No.
040720
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Who are the key members and board of directors at Purlin Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Bagga  | Director | 09-Feb-2017 | Current |
| Falak Bagga | Director | 21-Aug-2021 | Current |
Financial Performance of Purlin Pharma.
Purlin Pharma Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 13.29% decrease. The company also saw a substantial fall in profitability, with a 60.45% decrease in profit. The company's net worth Soared by an impressive increase of 163.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Purlin Pharma?
In 2018, Purlin Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Purlin Pharma?
Unlock and access historical data on people associated with Purlin Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Purlin Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Purlin Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
